Clinical Trials for Castrate Resistant Prostate Cancer

Find clinical trials for castrate resistant prostate cancer. Discover research opportunities and treatment options in your area.

10 Active Trials Found

Showing 10 trials on this page

Page 1 of 1

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

NCT ID: NCT06999187

This clinical trial is looking at a new treatment called DR-0202 for patients with certain types of advanced cancers, including triple-negative breast cancer and non-small cell lung cancer, among o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fairfax, Virginia, United States, Denver, Colorado, United States +8 more

TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors

NCT ID: NCT04969315

This clinical trial is investigating two new treatments, called TT-10 and TT-4, both alone and in combination, for patients with advanced solid tumors like kidney cancer, prostate cancer, lung canc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Louisville, Kentucky, United States +7 more

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

NCT ID: NCT05766371

This clinical trial is investigating a combination treatment for men with metastatic castration-resistant prostate cancer (mCRPC), which is a type of prostate cancer that continues to grow despite ...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Francisco, California, United States

Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer

NCT ID: NCT06527690

This clinical trial is looking at how effective a combination of three medications—Niraparib, Abiraterone Acetate, and Prednisone—works in treating a specific type of prostate cancer called metasta...

Not yet recruiting

Phase: PHASE2 Type: interventional

Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer

NCT ID: NCT06783127

This clinical trial is studying the effects of a medication called olaparib on men with a specific type of prostate cancer known as metastatic castration-resistant prostate cancer (mCRPC). The goal...

Recruiting

Type: observational Locations: Napoli, , Italy, Trento, , Italy

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

NCT ID: NCT05488548

This clinical trial is studying a new treatment called EP31670, which is designed to help patients with certain advanced cancers, including castrate-resistant prostate cancer, NUT carcinoma, chroni...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Boston, Massachusetts, United States +4 more

Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA

NCT ID: NCT04319783

This clinical trial is studying the combination of a drug called darolutamide and a type of treatment known as consolidation radiotherapy for men with advanced prostate cancer. Specifically, it foc...

Recruiting

Phase: PHASE2 Type: interventional Locations: Adelaide, South Australia, Australia, Hobart, Tasmania, Australia +17 more

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

NCT ID: NCT06395519

This clinical trial is studying a new medication called ETX-19477, which targets a specific enzyme involved in cancer growth. Researchers want to find out how safe the drug is, how the body process...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Houston, Texas, United States +3 more

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

NCT ID: NCT05627752

This clinical trial is studying the effects of a combination of two cancer treatments, docetaxel and enzalutamide, in men who have advanced prostate cancer that has become resistant to hormonal the...

Recruiting

Phase: PHASE2 Type: interventional Locations: Wuhan, Hubei, China

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

NCT ID: NCT05415098

This clinical trial is studying a new medication called APG-5918 to see how safe it is and how well it works for patients with advanced solid tumors or certain types of lymphomas, including nasopha...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Haven, Connecticut, United States, Springdale, Arkansas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions